Ibandronate sodium is a bisphosphonate medication mainly used to treat and prevent osteoporosis in postmenopausal women. It helps reduce the risk of vertebral fractures by increasing bone mineral density (BMD) and slowing bone loss. It is grouped under the following drug class(es): Bisphosphonates. Its therapeutic use is listed as anti-osteoporosis agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Bondronat, Boniva and Ibandronate sodium anhydrous. Its PubChem CID is 23670359.
Ibandronate sodium
| CAS No | 138844-81-2 |
|---|---|
| Molecular Formula | C9H22NNaO7P2 |
| Molecular Weight | 341.21 g/mol |
| Synonyms | sodium;hydroxy-[1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl]phosphinate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Ibandronate sodium is a bisphosphonate medication mainly used to treat and prevent osteoporosis in postmenopausal women. It helps reduce the risk of vertebral fractures by increasing bone mineral density (BMD) and slowing bone loss.
The listed CAS number is 138844-81-2.
The listed molecular formula is C9H22NNaO7P2.
The listed molecular weight is 341.21 g/mol.
sodium;hydroxy-[1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl]phosphinate.
The source lists Bondronat, Boniva and Ibandronate sodium anhydrous.